Selective iGluR5 receptor antagonists
    6.
    发明授权
    Selective iGluR5 receptor antagonists 失效
    选择性iGluR5受体拮抗剂

    公开(公告)号:US07157582B2

    公开(公告)日:2007-01-02

    申请号:US11032759

    申请日:2005-01-11

    IPC分类号: C07D217/12

    摘要: The present invention provides a method of treating or preventing migraine comprising administering to a patient in need thereof an effective amount of a selective iGluR5 receptor antagonist. The present invention further provides novel compounds functional as selective iGluR5 receptor antagonists as well as compositions and formulations comprising said selective iGluR5 receptor antagonists.

    摘要翻译: 本发明提供治疗或预防偏头痛的方法,其包括向有需要的患者施用有效量的选择性iGluR5受体拮抗剂。 本发明还提供了作为选择性iGluR 5受体拮抗剂的新型化合物以及包含所述选择性iGluR 5受体拮抗剂的组合物和制剂。